1-(4-CHLOROPHENYL)-2,5-PYRROLIDINEDIONE
- $110 - $567
- Product name: 1-(4-CHLOROPHENYL)-2,5-PYRROLIDINEDIONE
- CAS: 1628-19-9
- MF: C10H8ClNO2
- MW: 209.63
- EINECS:
- MDL Number:MFCD00034739
- Synonyms:1-(4-CHLOROPHENYL)-2,5-PYRROLIDINEDIONE;2-(4-CHLOROPHENYL)SUCCINIMIDE;3-(4-chlorophenyl)-pyrrolidine-2,5-dione;2,5-Pyrrolidinedione, 3-(4-chlorophenyl)-
4 prices
Selected condition:
Brand
- AK Scientific
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5MG
- 50mg
- 100mg
- 250mg
- ManufacturerAK Scientific
- Product number9906CM
- Product description2-(4-Chlorophenyl)succinimide
- Packaging100mg
- Price$425
- Updated2021-12-16
- Buy
- ManufacturerAK Scientific
- Product number9906CM
- Product description2-(4-Chlorophenyl)succinimide
- Packaging250mg
- Price$567
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0117261
- Product description2-(4-CHLOROPHENYL)SUCCINIMIDE 95.00%
- Packaging5MG
- Price$504.74
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberS762016
- Product description2-(4-CHLOROPHENYL)SUCCINIMIDE Aldrich
- Packaging50mg
- Price$110
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
AK Scientific | 9906CM | 2-(4-Chlorophenyl)succinimide | 100mg | $425 | 2021-12-16 | Buy |
AK Scientific | 9906CM | 2-(4-Chlorophenyl)succinimide | 250mg | $567 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | HCH0117261 | 2-(4-CHLOROPHENYL)SUCCINIMIDE 95.00% | 5MG | $504.74 | 2021-12-16 | Buy |
Sigma-Aldrich | S762016 | 2-(4-CHLOROPHENYL)SUCCINIMIDE Aldrich | 50mg | $110 | 2024-03-01 | Buy |
Properties
Boiling point :410.2±45.0 °C(Predicted)
Density :1.362±0.06 g/cm3(Predicted)
pka :9.01±0.50(Predicted)
Density :1.362±0.06 g/cm3(Predicted)
pka :9.01±0.50(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|